Skip to content
Journal

How AI is changing the corporate innovation lifecycle

The innovation lab used to exist to prove a concept before the core business would touch it. AI collapsed the cost of the proof, which moved the bottleneck somewhere the lab was never built to handle.

Building a working prototype used to take a quarter and a dedicated team, so the lab’s job was mostly logistics: get the resources, protect the timeline, produce the demo. That scarcity is mostly gone, a small team can produce a credible AI prototype in weeks.

A polished AI demo is no longer a signal of anything beyond effort.

What the lab was actually built to do

It is worth being precise about what the old scarcity was actually protecting, because the answer is not what most retrospectives on this shift assume. The lab was not primarily a filter for good ideas, it was a filter for ideas worth the operational cost of finding out. When a working prototype cost a quarter and a dedicated team, most of the lab’s real function was triage: deciding which of a hundred plausible ideas justified spending the one build slot available that period. The prototype itself was almost secondary to the resourcing decision that preceded it.

That triage function quietly did double duty as a thesis-discipline forcing mechanism, even though nobody described it that way at the time. Scarcity forced specificity. A team asking for a quarter of engineering time to test an idea had to articulate, in writing, precisely what they believed and precisely what result would prove them wrong, because a vague ask did not survive a resourcing committee. The cost of building was, in effect, subsidising the cost of thinking clearly about what was being built and why. Remove the cost of building and you do not automatically get to keep the clear thinking that used to be a side effect of it.

The bottleneck moved from building the thing to deciding which thing. When ten prototypes are cheap, the constraint becomes picking the one worth a real commitment, thesis discipline, not production speed. A working prototype with no internal buyer dies in committee, so the lab now needs a GTM motion inside the company, not just outside it. And the core business has to be willing to operate what the lab proves, which is an organisational problem the lab cannot solve alone.

Why a convincing demo stopped being a useful signal

The specific failure mode worth naming is what happens to a committee’s judgement once every proposal in front of it clears the bar that used to be the hard part. When five teams show up with five polished, working AI demos, all in the same review cycle, the committee’s attention naturally gravitates toward whichever demo is most impressive in the room, because polish is the only variable left that is easy to compare across five otherwise-similar-looking pitches. That is precisely the wrong variable to optimise a portfolio decision around, and it is a predictable consequence of removing the old cost filter without replacing it with a new one.

A polished demo now correlates with how much effort a team put into the demo, not with how validated the underlying thesis is, and those two things used to be the same signal by accident, back when producing a working demo at all required real conviction to justify the spend. Once conviction is no longer a prerequisite for producing something that looks convincing, the two signals decouple, and a committee that has not updated its evaluation criteria is effectively scoring a beauty contest while believing it is scoring a business case.

For corporate venture teams, this changes what diligence should test. The question that matters is whether the venture has a thesis specific enough to be wrong, and whether anyone inside the company is actually accountable for scaling it if it works, not how convincing the demo looked in the room. Naming the actual stage a venture is in, against the stage the team pitching it believes it is in, is the more useful diagnostic than any amount of additional demo polish, a team can be entirely sincere about their progress and still be reading their own stage wrong, which a good diligence process should be built to catch rather than take on faith.

The organisational problem the lab cannot solve alone

The internal-buyer problem deserves more weight than it usually gets in how innovation programs are structured, because it is where most technically sound prototypes actually die, not in the build, in the handoff. A prototype that proves a thesis externally still needs someone inside the core business willing to operate it, staff it, and defend its budget line once the initial novelty has worn off. That person needs to exist and be named before the prototype starts, not recruited after it succeeds, because recruiting an internal owner for something that already works is a much harder sell than recruiting one for something that might.

This is the same distribution problem that shows up in how a studio actually delivers on a build engagement rather than just handing over a deliverable, a working artefact with nobody accountable for what happens to it next is not actually finished, it is paused. The lab’s job, correctly scoped, does not end at "prototype validated." It ends at "a named internal owner has accepted the thing and is accountable for what happens to it," which is a harder, more organisationally uncomfortable bar to clear, and one that cheap prototyping does nothing to lower.

Innovation labs are not obsolete, but their job description changed: fewer prototypes shipped, more theses tested to a real yes-or-no, with an internal owner named before the prototype starts.

What a better lab actually measures

A lab correctly recalibrated for this environment tracks a different set of numbers than the one built around scarce build capacity. The old scorecard rewarded throughput, prototypes shipped, demos delivered, quarters used efficiently, because throughput was genuinely the constraint. The new scorecard has to reward something closer to decision quality: how many theses were stated specifically enough to be falsified, how many were actually killed when the evidence said to kill them rather than kept alive by momentum, and how many that survived had a real internal owner in place before anyone called them a success.

None of those are vanity metrics, and none of them are comfortable to report upward, which is exactly why most labs have not made the switch yet. "We shipped twelve prototypes this quarter" is a good headline in a board deck. "We killed nine of the twelve because the thesis did not hold, and the three that survived each have a named owner accountable for what happens next" is a better description of what actually happened, and a much harder sentence to say in a room that is still measuring the old way.

The teams making this transition well are not the ones building more prototypes faster, that part was never the constraint, and getting faster at it now mostly just produces more noise for the committee to sort through. They are the ones who rebuilt the committee’s own evaluation criteria before the build capacity changed underneath it, so the organisation is judging theses on specificity and ownership rather than on how good the demo looked in the room. That rebuild is organisational work, not technical work, and it is the actual bottleneck now, which is precisely the argument this piece opened with, just applied one level up, to the committee evaluating the labs rather than the labs evaluating the ideas.

A question worth asking before the next review cycle

There is a simple test a corporate venture team can run on itself before the next round of prototype reviews, and it does not require new tooling or a consultant to administer: pull the last ten ideas that went through the lab and sort them not by whether they shipped a working demo, but by whether the person pitching them could state, in one sentence, the specific evidence that would have made them stop. Most organisations that have not yet adjusted to cheap prototyping will find that number is uncomfortably low, plenty of confident pitches, few falsifiable ones.

That exercise is uncomfortable precisely because it surfaces how much of the old discipline was borrowed from scarcity rather than built on purpose. A team that has never had to justify a build in front of a resourcing committee has never had to practise the specific skill of stating a thesis sharply enough that it could be proven wrong, and that skill does not appear automatically just because the cost of building fell. It has to be taught, or hired for, or built into the review process deliberately, the same way the old scarcity built it into the process by accident.

The organisations getting ahead of this are not the ones with the most sophisticated AI tooling internally, tooling access converged fast across the whole market, the same way it did for every team building agentic products in the open market. They are the ones that noticed the scarcity was doing hidden work, named what that work actually was, and rebuilt a deliberate version of it before the absence of scarcity turned into an absence of discipline. That is a smaller, less glamorous project than standing up a new AI lab, and it is the one that actually determines whether the next generation of prototypes produces real commitments or just a faster-moving pile of demos nobody is accountable for.

Where this leaves the lab’s actual mandate

None of this argues for slowing the lab down or reintroducing artificial scarcity to force discipline back into the process, that would be solving a real problem with a fake constraint, which tends to produce its own distortions, usually in the form of teams gaming whatever gate gets reintroduced rather than genuinely internalising the discipline it was meant to enforce. The build speed is a real gain and there is no case for giving it back, quietly or otherwise.

What the lab’s mandate actually needs is a second, explicit skill sitting alongside the build capability: someone whose job is specifically to hold a thesis to a falsifiable standard before it ever reaches a prototype stage, independent of who is excited about the idea or how strong the internal champion’s track record is. That role did not need to exist when scarcity did the job automatically. It needs to exist now, deliberately, or the committee downstream inherits a filtering problem the lab was quietly solving for free until the cost of building fell out from under it. In practice this is closer to an internal diligence function than a design or engineering role, its output is a sharper thesis or an honest kill decision, not another artefact for the portfolio.

The uncomfortable version of this argument, stated plainly: a corporate innovation function that has not restructured itself around this shift is currently running on borrowed discipline from a scarcity that no longer exists, and the borrowing is not visible yet because the demos still look good. It becomes visible exactly once, at the moment several confidently-pitched, well-built prototypes fail in market at the same time, for reasons that a specific enough thesis would have surfaced months earlier. Fixing the evaluation process before that moment is a strictly cheaper fix than fixing it after, the same logic behind naming a stuck stage honestly before a board meeting forces the admission for you.

A useful comparison, because it makes the same shift visible in a more public setting: a product marketed with more confidence than its actual stage supports fails for structurally the same reason a well-built internal prototype fails after skipping this discipline, the story outran the evidence, and nobody in the room was positioned to say so before the market did. Internally, the market is the committee, and it is far more forgiving of an honest "not yet" than it will ever be of a confident claim that turns out not to have been earned. The lab that gets this right is not the one with the best build capability. It is the one willing to say "we do not know yet" out loud, in a room, before the evidence forces the admission for it.

Highlights
Cheap prototyping moved the real constraint from building to deciding what deserves commitment.
A prototype with no internal buyer dies in committee: distribution has to work inside the company too.
Diligence should test thesis specificity and ownership, not demo polish.
Rate this piece
Was this useful?
Comments
RA
R. Anand
This matches what we saw shipping our own agent last quarter, the debugging story alone justified the switch.
Journal

More writing like this.

Long-form on brand, product and venture craft in the AI era.

Read the Journal